The physiologic balance between the two reg-
both primary colony formation in methylcellulose and the recovery of clonogenic cells from suspension culture. Strikingly, in the samples from the entire group of patients, 8-ClcAMP was more effective in inhibiting the self-renewing donogenic cells than the terminally dividing blast cells (P = 0.005). In addition, in four out of six cases studied, 8-Cl-cAMP was able to induce a morphologic and/or immunophenotypic maturation ofleukemic blasts. An evident reduction ofRI levels in fresh leukemic cells after exposure to 8-Cl-cAMP was also detected. Our results showing that 8-Cl-cAMP is a powerful inhibitor of clonogenic growth of leukemic blast progenitors by primarily suppressing their self-renewal capacity indicate that this site-selective cAMP analog represents a promising biological agent for acute myeloblastic leukemia therapy in humans.
The progressive accumulation of leukemic cells in acute myeloblastic leukemia (AML) is sustained by a small population of leukemic blast progenitors (1, 2) . Leukemic blast progenitors, like normal hemopoietic stem cells, are able to renew themselves and/or undergo terminal divisions giving rise to nonrenewing end cells that, however, do not achieve morphological maturity (2, 3) . The self-renewal capacity of blast progenitors has been shown to be highly correlated with clinical outcome in AML (4) (5) (6) .
Currently, however, no means are available to distinguish between the "determined" and "self-renewing" blast cells on morphological, phenotypical, or molecular grounds. McCulloch and associates (2, 7) have developed the only culture method to date that is able to make an operational distinction between the self-renewal and postdeterministic mitoses. The culture method consists of two different assays: (i) direct semisolid medium (methylcellulose) cloning and (ii) a 7-day liquid culture, after which cells are replated in a methylcellulose cloning assay. Conclusive evidence has been provided that, during the liquid culture, self-renewing clonogenic cells increase exponentially and are selected against determined but still dividing blasts, so that they can be specifically assayed in the subsequent cloning assay (8) . Thus, in the primary methylcellulose cloning, determined clonogenic cells can be enumerated, while the secondary cloning following liquid culture allows the quantitations of self-renewing clonogenic cells (8, 9) . Most importantly, this method represents a predictive in vitro model for evaluating the therapeutic efficacy of anticancer agents in AML (1, 2, 6, 7). In vitro evaluation of self-renewing clonogenic cells and their inhibition by different drugs, as described by McCulloch and associates (2, 4) , have been significantly associated with the clinical outcome and response to therapeutic agents administered in vivo to AML patients (2, 4, 6, 7) . To eradicate AML, it is therefore important to search for antitumor agents that can inhibit not only terminal divisions, like most cytotoxic drugs (10, 11) , but also can inhibit self-renewal of leukemic blast progenitors.
Previous studies have shown that site-selective cAMP analogs are able to induce potent growth inhibition and differentiation in a broad spectrum of cancer cells (12) , including human leukemia cells (13, 14) . Site-selective cAMP analogs bind selectively to sites present on each of the two regulatory subunits of the cAMP-dependent protein kinases, type I (RI) and type II (RII) (15) (16) (17) , respectively. Inhibition of cancer cell growth by 8-chloroadenosine 3',5'-cyclic monophosphate (8-Cl-cAMP), the most potent site-selective cAMP analog, is accompanied by a reduction in the levels of the RI cAMP receptor protein and an increase in RII levels (13, 14, 18) . Accordingly, an accumulation of the RI subunit has been associated with growth stimulation and neoplastic transformation, whereas an increase in the RII subunit has been related to growth arrest and cell differentiation (12, 19, 20) . Site-selective cAMP analogs represent a promising additional class of antitumor agents; however, their prospective impact in the therapy of human leukemias remains to be fully Table 1 ) and confirmed by cytochemistry and flow cytometry immunophenotyping. Ficoll/Hypaqueisolated blast cells were T-cell-depleted as described (22) For suspension cultures, cells (2 x 105/ml) were incubated in the presence of 10% 5637-CM and increasing concentrations of 8-Cl-cAMP in six-well microplates. After 7 days, nonadherent cells were harvested, counted, washed twice in Dulbecco's modified Eagle's medium to remove 8-Cl-cAMP, and replated in analog-free methylcellulose as described above. Colonies grown in this assay yielded a plating efficiency after suspension culture (PEs). The number of selfrenewing clonogenic cells was expressed as the number of colonies (PEs) adjusted for the number of nonadherent cells present in 1 ml of suspension culture (clonogenic cell recovery) (2, 10, 23).
Simple negative survival curves were computed by linear regression by comparing the number of clonogenic cells, derived from suspension culture or methylcellulose culture at each dose of 8-Cl-cAMP, with controls. From these curves, the doses required to reduce survival to 10% (D10) and 50% (D50) of the control, respectively, were obtained.
Survival curves were also obtained from experiments performed either without growth factors or by using a serumfree medium (26) or medium supplemented with serum-free 5637-CM (27) . The effects of such culture manipulations were inferred from the multiple parameters obtained from methylcellulose or suspension cultures and were conveniently integrated in a star diagram (28, 29) .
Morphological Studies and Cell Surface Antigen Analysis. In selected cases (cases 6, 9, 11, 12, 17, and 18), blast cell morphology and immunophenotypic changes were assessed by May-Grunwald-Giemsa staining of cytospin preparations and flow cytometry analysis of 7-day-old liquid cultures performed in the presence of 8-Cl-cAMP (1-50 ,uM). Modulation of cell surface antigens (CD11b/Mol, CD13/My7, CD14/My4, CD33/My9, CD71/anti-transferrin receptor, and CD15/OKM15) was analyzed by a FACScan cytofluorograph (Becton Dickinson) as described (30) .
Photoafflnity Labeling of cAMP Receptor Proteins. Preparation of cell extracts and photoactivated incorporation of 8-azidoadenosine 3',5'-cyclic [32P]monophosphate followed the method previously described (13, 18) . The samples containing 25-50 Ag of protein were subjected to electrophoresis in 0.05% SDS/12% polyacrylamide gels (18) , and the separated proteins were transferred to nitrocellulose sheets (18) . The sheets were air dried and exposed to Kodak XAR film overnight at -20'C.
Statistical Analysis. Mean values, standard errors (SE), and 95% confidence intervals for the means were computed (31) .
Statistical differences between means were tested by Student's t test (31) . D10 and D50 values for 8-Cl-cAMP were determined from the slope of negative exponential doseresponse survival curves computed by linear regression and were compared as described (31) .
RESULTS
Effects of 8-Cl-cAMP on Self-Renewal and Terminal Divisions of Leukemic Blast Progenitors. Representative doseresponse survival curves of leukemic blast progenitors are shown in Fig. 1 . Exposure to 8-Cl-cAMP (0.1-50 uM) resulted in a dose-dependent inhibition of blast cells both in the primary methylcellulose cloning and the secondary cloning after suspension culture. Survival curves are depicted by standard slope parameters D10 and D50, which represent the concentration of 8-Cl-cAMP required to reduce survival to 10% and 50o of controls, respectively (Table 1) . In blast cells from all patients, 8-Cl-cAMP showed a striking inhibitory effect on colony growth after suspension culture. D10 and D50 mean values in methylcellulose were higher (P = 0.005) than in suspension (Table 1 ). According to their patterns of response to 8-Cl-cAMP, we divided our samples into three subgroups operationally termed A, B, and C (Fig. 1) . These subgroups were mathematically defined by statistically significant differences between D10 (or D50) mean values in methylcellulose and in suspension. In each of the three groups, 95% confidence intervals were never overlapping (data not shown). These subsets, however, did not correlate with the FAB classification or with the clinical state of patients and more likely reflect a biological heterogeneity within the AML group ( cellulose cultures were inhibited by 8-Cl-cAMP, but a more marked effect in suspension was observed. 8-Cl-cAMP dosesurvival curves of blast progenitors from these two groups were similar to those obtained with ara-C, a cytotoxic drug previously shown primarily to suppress self-renewal of AML progenitors (7). In the third group (group C; patients 5, 9, 11, 12, and 16), clonogenic cells recovered in suspension or grown in semisolid medium were similarly suppressed, as described for the anticancer drugs adriamycin and 4-hydroperoxycyclophosphamide (7, 11) . Finally, in two patients from this group, culture conditions favoring self-renewal rather than terminal divisions resulted in an increased sensitivity of leukemic progenitors to 8-Cl-cAMP in suspension (see below). Effects of Culture Conditions Favoring Self-Renewal or Terminal Divisions of Leukemic Blast Progenitors on Sensitivity to 8-Cl-cAMP. Star diagrams and 8-Cl-cAMP dosesurvival curves after suspension culture of blast cells from two patients cultured in conditions favoring self-renewal or terminal divisions are shown in Fig. 2 . In case 9 ( Fig. 2A  Inset) , serum-containing medium strongly enhanced blasts' self-renewal, as evidenced by the star diagram displaying high values for the self-renewal-related parameters PEs and clonogenic cell recovery. Conversely, in serum-free cultures, self-renewal-related functions were decreased and terminal divisions were favored, as shown by an increased PEmc. Dose-survival curves ( Fig. 2A) showed that blast cells from patient 9 were more sensitive to 8-Cl-cAMP under culture conditions where self-renewal mitoses are favored [serumcontaining medium (SCM) vs. serum-free medium (SFM)] (P < 0.001). For blast cells from patient 5 (Fig. 2B Inset) , analysis of star diagrams showed that growth in the absence of growth factors was characterized by higher self-renewal values (PEs and clonogenic cell recovery) compared with cultures with serum-free 5637-CM in which a low PEs was detected. Again, survival curves (Fig. 2B) sensitivity to 8-Cl-cAMP. Blasts from patients 6, 9, 11, and 18, exposed for 7 days to 8-Cl-cAMP (1-50 AuM), did not show any significant morphological changes when compared with controls. In contrast, the blast cells from two patients (patients 12 and 17) were induced to differentiate by 8-Cl-cAMP as shown by morphological changes consistent with granulocytic (case 17; Fig. 3 A-D) or monocytic (case 12; Fig. 3 E and F) differentiation and by a striking upregulation of the mature granulocytic (CD15) and monocytic (CD14) antigens (Fig. 3 G and H) . A significant reduction in the expression of the early myeloid antigen CD33 and of the proliferationassociated transferrin receptor (CD71) was also observed in both cases. Interestingly, in cells from patients 9 and 18, exposure to 8-Cl-cAMP, although not inducing a morphological maturation, resulted in a significant downregulation of CD33 and CD71 antigens. 3) ; lanes R1. and RIla, rabbit skeletal muscle RIa and bovine heart muscle RILa, respectively. phate followed by SDS/PAGE. As shown in Fig. 4 , untreated control cells from three AML patients each exhibited a major band of48-kDa, which comigrated with rabbit skeletal muscle RI., that we refer to as RI,. Minor bands of 65-, 44-, and 37-kDa proteins were also identified; the 44-and 37-kDa bands, which could be displaced by the addition ofa 1000-fold excess of unlabeled cAMP, may represent proteolytically degraded cAMP-binding proteins, whereas the 65-kDa protein band, which shows partial displacement by excess cAMP and comigrates with bovine serum albumin, exhibits nonspecific cAMP binding. Treatment ofthese cells with 8-Cl-cAMP (5 ,gM) for 3 days resulted in an almost complete abolishment of RI. and a decrease in the minor cAMP-binding proteins.
However, a decrease was not observed in the 65-kDa protein, the nonspecific binding protein (Fig. 4) . RII cAMP-binding protein was not detected in either untreated control cells or in cells treated with 8-Cl-cAMP (Fig. 4) .
DISCUSSION
In the present study, we examined the ability of a siteselective cAMP analog, 8-Cl-cAMP, to affect both terminal divisions (clonogenic growth in methylcellulose) and selfrenewal capacity (clonogenic growth after suspension culture) of AML blast cell progenitors. 8-Cl-cAMP was highly effective in suppressing leukemic blasts' colony formation in a dose-dependent manner. In addition, in 10 of 15 samples, 8-Cl-cAMP was more effective in inhibiting clonogenic cells grown in suspension than primary colonies grown in methylcellulose. From these data, it can be concluded that 8-ClcAMP is a powerful inhibitor of blast cell growth, primarily affecting its self-renewal capacity.
The mechanisms underlying the preferential suppression of the self-renewal capacity by 8-Cl-cAMP remain to be determined, and at least two possibilities must be considered. One is that self-renewal of blast progenitors is directly suppressed by 8-Cl-cAMP. High levels of RI cAMP receptor proteins have been associated with active cell growth, neoplastic transformation, and early stages of differentiation (12, 20, 32, 33) , whereas a RI decrease and/or increase in RII correlate with growth arrest and maturation in a variety of cell types, including human leukemic cells (13, 14) . It is conceivable that an actively self-renewing subpopulation of blast progenitors may display higher levels ofRI subunits compared with blasts committed to terminal divisions, resulting in greater sensitivity to 8-Cl-cAMP. Whether changes in culture microenvironment that modify the balance between self-renewal and terminal divisions would alter RI and RII relative levels in fresh AML blasts remains to be determined. The marked alteration in sensitivity of leukemic cells to 8-Cl-cAMP that we observed after manipulation of culture conditions in two Medical Sciences: Pinto et al.
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AML samples strongly supports such a view (Fig. 2) . The growth-inhibitory potency of site-selective cAMP analogs is dependent on RI and RII relative levels in target cells (12, 20, 32, 33) . Our results have shown that RIE levels in fresh cells from AML patients are dramatically decreased by exposure to 8-Cl-cAMP. Another explanation for our results is that 8-Cl-cAMP might induce terminal divisions and differentiation of blast progenitors, with a consequent reduction of their self-renewal capacity. Such a possibility is in agreement with the demonstration that site-selective cAMP analogs, including 8-Cl-cAMP, are able to induce morphologic and/or functional differentiation of the human leukemic cell lines HL60 (13) and K562 (14) . In the present study, blast cells from two of six patients were induced to differentiate by 8-Cl-cAMP, as evaluated by morphological and immunophenotypical changes, and in two other cases cell surface modifications compatible with a shift toward a mature phenotype were obtained. In operational terms, therefore, 8-Cl-cAMP, like any biological agent able to induce the loss of self-renewal in leukemic cells (without causing acute cell killing), can be considered a "differentiation inducer" even if not all mature phenotypic markers are acquired as a result of its action. As a matter of fact, the majority of so-called differentiation inducers, including those currently adopted in clinical trials, can cause a cytological and phenotypical maturation in a relatively low percentage of fresh AML cells in vitro (34) while inducing an almost total abolishment of the clonogenic capacity of the whole cell population. Thus, the noncytologically mature cells are, notwithstanding, "functionally differentiated" as long as they lack the stem cell property of self-renewal. From our data it clearly appears that 8-ClcAMP induced functional differentiation (i.e., the loss of self-renewal) in almost all blast cell progenitors in all the samples; in addition, it further pushed the differentiation program (i.e., acquisition of cytological and/or surface markers) in four of six samples tested (i.e., 66%). On the other hand, it is most probable that AML cells are rendered by 8-Cl-cAMP sensitive to other differentiation signals (i.e., hemopoietic growth factors) and that the combination of more than one factor is required to bring about the entire differentiation program in AML cells.
The preferential inhibition of the self-renewal capacity of AML progenitors by 8-Cl-cAMP demonstrated by us in the present study suggest another approach in AML therapy. Self-renewal capacity of leukemic cells is strictly correlated with the clinical outcome in AML (4-6); patients in which blast progenitors display a high self-renewal capacity in vitro have a low probability of achieving complete remission and show a low survival rate (4-6). The availability of biological agents inhibiting the self-renewal capacity of leukemic stem cells provides a very useful tool for AML therapy, since a cure in these patients may be achieved only if blasts' selfrenewal is completely abolished. We have shown here that 8-Cl-cAMP, at micromolar concentrations, provokes a drastic suppression of AML clonogenic cells by primarily affecting their self-renewal capacity. Our data strongly indicate that 8-Cl-cAMP may represent a promising additional agent for AML therapy in humans.
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